Navigation Links
OLIGOMERIX, Inc. Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer

NEW YORK, Oct. 13 /PRNewswire/ -- OLIGOMERIX, Inc. announced today that Vic Micati, a Director since 2007, has been appointed Chairman of Oligomerix and that Jack Pasini has been appointed to the Company's Board of Directors and as Chief Commercial Officer.  

Having worked at Pfizer Inc. (PFE) for nearly 40 years, Mr. Micati was a member of Pfizer's Corporate Management Committee responsible for all aspects of global operations. He also served as Executive Vice President of the Pharmaceutical Group and Vice President of Pfizer Inc. He was appointed to the International Board of Directors in 1984 and became President of Pfizer's European operations in 1990.

Since 1999, Mr. Micati has worked as a consultant in the pharmaceutical industry and served on the board of several companies including Ilex Oncology (ILXO), subsequently acquired by Genzyme Corporation (GENZ), ENZON Pharmaceuticals Inc. (ENZN) and was member of the Advisory Board of Almirall, a Spanish pharmaceutical company.

Mr. Pasini is also a seasoned executive, having gained broad global commercial leadership experience during a 30-year career with Pfizer. Formerly, Mr. Pasini was Vice President, Worldwide Marketing responsible for Pfizer's Anti-Infective and Allergy/Respiratory Therapeutic Groups.  He also served as Vice President of Product Development, Regional President of the Africa, Middle East Region, and Vice President of Business Intelligence & Planning.  Mr. Pasini served on the board of the American Lung Association of the City of New York for five years.  Since his retirement in 2007, Mr. Pasini has worked as a consultant in the pharmaceutical industry.

"We are very pleased that Vic has agreed to take on the role of Chairman of Oligomerix and that Jack has agreed to join the Oligomerix Board and serve as Chief Commercial Officer.  We anticipate that Jack will play a key role in developing important partnerships within the industry to facilitate our transition into a full-scale biotechnology company," said James Moe, President & CEO.


OLIGOMERIX, Inc. is a biopharmaceutical company founded in 2006 located within the Audubon Biomedical Science and Technology Park of Columbia University. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer's and other neurodegenerative diseases.  For more information visit Contact:Tiberend Strategic Advisors, Inc.212-827-0020Farrell

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy
2. Boston Scientific Announces Global Launch of Journey™ Guidewire
3. Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
4. CORRECTED - Akorn, Inc. Announces Date Change for Third Quarter 2010 Earnings Release and Conference Call
5. Prime Therapeutics Announces URAC Accreditation
6. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
7. Cellectis bioresearch Announces Establishment of Subsidiary in the US
8. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
9. Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data
10. Misonix Announces Change in Distribution of SonaStar® Surgical Aspiration System in the U.S.
11. Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):